From the September quarterly activities
• Lower unit cash operating costs1 of US$355/dmt.
So around $6.5m profit for the Dec quarter?
I reckon that’s not that bad but maths wasn’t my strongest subject. So correct me if I’m wrong.
Spodumene Prices, page-28
-
- There are more pages in this discussion • 4,555 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.82 |
Change
-0.100(3.42%) |
Mkt cap ! $8.668B | |||
| Open | High | Low | Value | Volume |
| $2.89 | $2.92 | $2.82 | $29.00M | 10.09M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 53 | 300923 | $2.82 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.83 | 300048 | 79 |
View Market Depth
| Last trade - 13.10pm 30/07/2024 (20 minute delay) ? |
| PLS (ASX) Chart |